-

01:30:10 PM

GENE Stock News

GENE - Genetic Technologies Ltd.

10/25/21 8:30 AM

Nasdaq : GENE

low float

Genetic Technologies Reports Q1 FY22 Results

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics

RHEA-AI

very positive

10/04/21 8:00 AM

Nasdaq : GENE

low float

GENE Delivers Material 12-Fold Increase in Revenue in the Quarter Ended September 2021

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease, announces a 12-fold increase in revenue

RHEA-AI

neutral

09/30/21 9:00 AM

Nasdaq : GENE

low float

Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S.) on the RedChip Money Report®

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious disease, today announced that an interview with CEO Simon Morriss, discussing the advancements

RHEA-AI

neutral

09/28/21 8:04 AM

Nasdaq : GENE

low float

GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business today announced

RHEA-AI

positive

09/09/21 9:00 AM

Nasdaq : GENE

low float

BelHealth Completes Asset Sale of General Genetics Corp.

September 9, 2021–BelHealth Investment Partners, LLC ("BelHealth") is pleased to announce that it has completed the sale of assets of the international division of General Genetics Corporation (GGC), a provider of relationship and clinical

RHEA-AI

very positive

08/31/21 9:00 AM

Nasdaq : GENE

low float

Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in

RHEA-AI

positive

08/16/21 8:00 AM

Nasdaq : GENE

low float

Genetic Technologies Enters Multi-Billion-Dollar Consumer Genomics Market

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in Genomics based tests in health, wellness and serious disease, is pleased to announce the

RHEA-AI

neutral

07/26/21 8:25 AM

Nasdaq : GENE

low float

Genetic Technologies Rapidly Accelerating Commercialization Plans

Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious disease, is pleased to provide its Quarterly Business Update to the market. Highlights Revenues from

RHEA-AI

very positive

07/19/21 8:00 AM

Nasdaq : GENE

acquisitionlow float

Genetic Technologies Strengthens Global Leadership in Genomics with Acquisition of EasyDNA

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics tests in health, wellness and serious disease, has signed an

RHEA-AI

positive

07/09/21 8:00 AM

Nasdaq : GENE

low float

Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities

Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE, "Company", "GTG"), a diversified Genomics and AI driven preventative health business, today announced updates on the development of its Predictive Panel Risk Test designed to cover six

RHEA-AI

very positive